Diethyl Hydrogen Phosphate

Diethyl Hydrogen Phosphate

SCHEMBL3069452

CCCC[P+](CCCC)(CCCC)CCCC.CCOP(=O)([O-])OCC

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 2/20 0.44
CYP3A4 P08684 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 2/20 0.41
AKT1 P31749 2/20 0.41
ESR1 P03372 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
CDC25A P30304 1/20 0.41
AGTR1 P30556 1/20 0.41
ADRA1A P35348 1/20 0.41
KCNH2 Q12809 1/20 0.41
FDPS P14324 1/20 0.39
TSHR P16473 1/20 0.37
PLA2G1B P04054 1/20 0.35
PLA2G2A P14555 1/20 0.35
PRKD3 O94806 1/20 0.35
PRKCG P05129 1/20 0.35
PRKCB P05771 1/20 0.35
PRKCA P17252 1/20 0.35
PRKCH P24723 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethyl Hydrogen Phosphate SCHEMBL27984258 0.94 DNM1 (0.56) DNM1CYP3A4L3MBTL1LMNAAKT1
Diethyl Hydrogen Phosphate SCHEMBL3072648 0.94 DNM1 (0.48) DNM1CYP3A4L3MBTL1LMNAAKT1
Diethyl Hydrogen Phosphate SCHEMBL27159611 0.92 DNM1 (0.52) DNM1LMNAAKT1ESR1ADORA3
Diethyl Hydrogen Phosphate SCHEMBL3072636 0.92 DNM1 (0.52) DNM1LMNAAKT1ESR1ADORA3
Diethyl Hydrogen Phosphate SCHEMBL344448 0.92 CYP3A4 (0.43) DNM1CYP3A4L3MBTL1LMNAAKT1
SCHEMBL14576108 0.90 DNM1 (0.40) DNM1CYP3A4L3MBTL1LMNAAKT1
SCHEMBL26929099 0.88 DNM1 (0.44) DNM1CYP3A4L3MBTL1FDPSTSHR
Diethyl Hydrogen Phosphate SCHEMBL3066739 0.87 TSHR (0.40) CYP3A4L3MBTL1LMNAAKT1ESR1
Diethyl Hydrogen Phosphate SCHEMBL27159812 0.86 CYP3A4 (0.40) CYP3A4L3MBTL1LMNAAKT1ESR1
SCHEMBL3069289 0.86 AKT1 (0.47) DNM1CYP3A4L3MBTL1LMNAAKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023238500-A1 TREATMENT AGENT FOR CARBON FIBER PRECURSOR, AND CARBON FIBER PRECURSOR 竹本油脂株式会社 2023-12-14 WO disclosed
EP-2540761-B1 CURABLE RESIN COMPOSITION MITSUBISHI GAS CHEMICAL CO (JP) 2016-08-31 EP disclosed
US-8853346-B2 Curable resin composition MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2014-10-07 US disclosed
US-20130018168-A1 CURABLE RESIN COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2013-01-17 US disclosed
EP-2540761-A1 CURABLE RESIN COMPOSITION Mitsubishi Gas Chemical Company, Inc. (JP) 2013-01-02 EP disclosed
US-20100267980-A1 CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2010-10-21 US disclosed
US-20090118442-A1 CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2009-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267980-A1 CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT ELL, RAD54L, RPP30 DNM1 2856/4885CYP3A4 3162/4885L3MBTL1 1175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.